News
May 23, 2018
Webcast Alert: Ionis Pharmaceuticals Provides Corporate Update at 2018 Annual Meeting of StockholdersFollow us on 
Spotlight
Ionis Pharmaceuticals Publishes Paper on Growth of RNA-targeted Therapeutics in Cell Metabolism
More »
IONIS NEURO-TTR Phase 3 Clinical Trial Highlighted at American College of Cardiology (ACC) Annual Meeting
More »
FDA Accepts Plazomicin’s NDA with Priority Review for the Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
More »
Ionis’ SPINRAZA Recognized with Prestigious Prix Galien Award for Best Biotechnology Product
More »
Clinical Trials
We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »
